FDA Adverse Event Malfunction Summary report: N

BENZODIAZEPINES PLUS

MDR report key: 4295848 · Received December 3, 2014

Report

Report Number
1823260-2014-09566
Event Type
Malfunction
Date Received
December 3, 2014
Date of Event
November 21, 2014
Report Date
December 15, 2014
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JXM
PMA / PMN Number
K043327
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IT IS UNKNOWN IF THE CUSTOMER REPORTED TO FDA.

Additional Manufacturer Narrative · 1

THE INVESTIGATION DETERMINED THAT LORAZEPAM GLUCURONIDES REACT WITH THE REAGENT AT APPROXIMATELY 0.5% CROSS-REACTIVITY. THE REAGENT DOES NOT CONTAIN GLUCURONIDASE. IT WAS DETERMINED THE ASSAY WAS WORKING ACCORDING TO SPECIFICATION AND CROSS-REACTIVITY CLAIMS.

Description of Event or Problem · 1

THE CUSTOMER ALLEGED INSTANCES WHERE A PATIENT WAS TAKING "LORAZEPINE" AND THE DOCTOR EXPECTED A POSITIVE RESULT FOR THE BENZODIAZEPINES PLUS ASSAY, BUT THE RESULT WAS NEGATIVE. TESTING BY MASS SPECTROMETER WAS POSITIVE FOR BENZODIAZEPINES. THE CUSTOMER STATED SHE KNEW OF "A COUPLE OF SAMPLES" THAT WERE EXPECTED TO BE POSITIVE DUE TO PATIENT MEDICATION, BUT WERE REPORTED AS NEGATIVE. FOLLOWING PHYSICIAN COMPLAINTS THE SAMPLES WERE TESTED BY MASS SPECTROMETRY AND WERE POSITIVE FOR BENZODIAZEPINES WITH RESULTS AS HIGH AS 12000 OR 15000 (NO UNITS OF MEASURE WERE PROVIDED). THE CUSTOMER COULD NOT PROVIDE THE ACTUAL DATES ON WHICH THESE EVENTS OCCURRED. NO PATIENTS WERE ADVERSELY AFFECTED. THE ANALYZER IN USE WAS A COBAS 8000 C 502 MODULE, SERIAL NUMBER (B)(4). THE FIELD SERVICE REPRESENTATIVE COULD NOT FIND A CAUSE AND INDICATED THE CUSTOMER DID NOT BELIEVE THERE TO BE A PROBLEM WITH THE INSTRUMENT. THE FIELD SERVICE REPRESENTATIVE RAN A PRECISION STUDY WHICH WAS ACCEPTABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
781686 BENZODIAZEPINES PLUS ENZYME IMMUNOASSAY, BENZODIAZIPINE JXM ROCHE DIAGNOSTICS NA 69386501

Patients

Seq Age Sex Outcome Treatment
1